Contents
Contents
Federal research grant fraud can use fabricated data, altered images or false statements to obtain or support funding. You may recognize the experiment behind a published figure and know that the image now represents a different condition, mouse or timepoint. When that result reaches a grant application or progress report, it can influence a federal funding decision. The person who knows what happened in the lab can explain what the government was told it was paying for.
A false certification misrepresents information or compliance that matters to the government’s payment decision. In a research grant, that can mean an investigator certifying the accuracy of an application containing altered results, or an institution certifying compliance while charging expenses the grant does not allow.
In its June 2026 testimony on research-grant fraud, the Justice Department explained that the False Claims Act reaches fraud involving federal contracts as well as grants. A grant application or a request to draw down funds can be a claim.
The application is where the government compares competing proposals and decides which research deserves funding. False descriptions of prior work can distort that comparison before the new experiments even begin. An accurate account of what the lab has already done is part of the case for what taxpayers should fund next.
In a grant application, altered images used to support funded research can misrepresent what an experiment found. The image and its description have to be read together: changing the label can change the scientific claim even when the underlying picture remains recognizable.
A 2021 Justice Department settlement shows that problem in a Massachusetts General Hospital-sponsored application to the National Institutes of Health. A laboratory fellow had conducted the experiments behind certain figures. By the time the principal investigator submitted the application, the fellow no longer worked for him.
The government alleged that the investigator changed the experiment descriptions in two figures, falsifying the results they represented. It alleged that he horizontally flipped a third image and mislabeled the results in the application.
The investigator also signed an assurance certifying the truth, completeness and accuracy of the application and confirmed that he had reviewed and approved it.
The scientist agreed to pay $215,000 to resolve the allegations, while Massachusetts General Hospital separately repaid every dollar it had drawn from the grant. The hospital had disclosed the alleged false statements to the government.
For someone who performed the underlying experiment, the useful detail may be the condition attached to an image. We connect that knowledge to the submitted figure, its description and the assurance accompanying it.
Dana-Farber Cancer Institute admitted that its researchers misrepresented data and images in scientific publications, and that grant applications discussed an article without disclosing its misrepresented or duplicated material. Its December 2025 settlement announcement describes specific changes an insider could recognize.
Images were reused to represent different experimental conditions. Duplicated images stood for different testing conditions, mice or timepoints. Images were also rotated, magnified or stretched. A repeated image was being asked to stand for different experimental evidence.
Dana-Farber agreed to pay $15 million over grant-related statements and certifications involving misrepresentations in 14 scientific journal articles.
The institute admitted spending money from six National Institutes of Health grants on unallowable expenses for the publications. It also admitted that a supervising researcher failed to exercise sufficient oversight over the researchers responsible.
Another researcher received four National Institutes of Health grants after submitting applications that discussed a journal article the researcher had authored. Those applications did not disclose that the article contained misrepresented or duplicated images and data.
The government contended that false compliance certifications, unallowable expenses and misleading applications caused false claims to the National Institutes of Health.
Duke University agreed to a $112.5 million settlement over allegations that falsified mouse research reached applications and progress reports for 30 federal grants. The Justice Department’s March 2019 announcement identified funding from the National Institutes of Health and the Environmental Protection Agency.
The government alleged that a technician’s mouse research in Duke’s Airway Physiology Laboratory, and statements based on that research, were falsified or fabricated. It alleged that Duke knowingly submitted or caused the submission of claims containing those results or statements, causing the agencies to pay grant funds they otherwise would not have paid.
The allegation reached both the underlying experiments and the institution’s later representations about them. A progress report gave the disputed results another route into the funding relationship. For a lab insider, the comparison therefore extends beyond the original application to what the institution later said the research had accomplished.
A former Duke employee brought the whistleblower case and pursued it on the government’s behalf after the government declined to take it over. The Justice Department said the whistleblower would receive $33.75 million from the settlement. The former employee’s case connected work inside a university laboratory to claims made in the university’s name.
A funding assurance can misstate which research a grant paid for. The Scripps Research Institute case shows how an insider’s knowledge of the work can expose a different discrepancy: time spent seeking new funding charged to projects that already had awards.
Scripps agreed in 2020 to pay $10 million to resolve allegations that existing National Institutes of Health projects paid for faculty time spent on new grant applications, teaching, committee work and administration without adequate effort accounting.
The former employee’s complaint alleged that Scripps expected faculty to cover their own salaries and benefits through grants and to generate grant funding for research staff salaries. The complaint put the resulting mismatch plainly:
For 2012 alone, 100% of Relator’s salary was charged to four federally awarded grants in different percentages. During 2012, however, he worked on six new grant applications and resubmissions, completing and submitting three of them during 2012, yet all of his time (salary) was improperly charged to already awarded and funded grants.
The complaint alleged that effort forms used unexplained internal account numbers and did not distinguish awarded-grant work from new applications, teaching or other activities. It also alleged that applications, reports, certifications and payment requests misrepresented the work performed. The salary charge and the scientist’s account of the working day told different stories.
Across these cases, an insider can connect the government’s paperwork to the work behind it.
For fabricated research in federal grant claims, the useful evidence connects the experiment, the representation, the assurance and the funding. We work through those connections with you, using the particular grant and the records you know.
A scientist may recognize that an image carries the wrong experimental description. A research administrator may know where that figure appeared in an application or report. The account of the experiment and the account of the submission belong together. We help connect them into a case about the representation the government relied on.
The Justice Department’s research-grant testimony explains why accurate descriptions of data and prior work matter: agencies use them to compare applications and select promising research. An altered result can give a proposal a scientific foundation the experiment never supplied. Taxpayers fund that representation, and honest applicants compete against it.
For your case, we examine what the application or report said, how it used the disputed result, who took responsibility for it and which funding it supported. Duke’s allegations about payments the agencies otherwise would not have made and Dana-Farber’s admissions about applications and spending give concrete examples of those connections.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The Duke case began with a former employee, and Dana-Farber’s settlement also resolved a whistleblower case. If your own role in preparing or approving a submission is part of the concern, our whistleblower experts can work through it with you.
If the figure in a grant submission tells a different story from the experiment you know, talk to our whistleblower experts about the research and the funding behind it. We work beside you to build your strongest research-grant whistleblower case, connecting the scientific evidence to the institution’s representations and the money. We stay with you through the whole case and bring in research-grant fraud whistleblower lawyers who understand image-manipulation evidence.